ArticleJournal of hematology & oncology2023

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.

Carolina Pavlovsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.